TELO (Telomir Pharmaceuticals, Inc. Common Stock) Stock Analysis - AI Report

Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a publicly traded Healthcare sector company. As of May 20, 2026, TELO trades at $1.26 with a market cap of $81.84M and a P/E ratio of 0.00. TELO moved +3.28% today. Year to date, TELO is -8.96%; over the trailing twelve months it is -51.97%. Its 52-week range spans $1.05 to $7.08. Rallies surfaces TELO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on TELO?

Rallies AI research for TELO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

TELO Key Metrics

Key financial metrics for TELO
MetricValue
Price$1.26
Market Cap$81.84M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$7.08
52-Week Low$1.05
Volume65.80K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest TELO News

Recent TELO Insider Trades

  • Aminov Erez sold 200 (~$1.20K) on Aug 19, 2024.
  • Aminov Erez sold 200 (~$1.24K) on Aug 19, 2024.
  • Bay Shore Trust bought 49.00K (~$343.00K) on Feb 13, 2024.

TELO Analyst Consensus

TELO analyst coverage data. Average price target: $0.00.

Common questions about TELO

What is the AI research view on TELO?
Rallies AI research for TELO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for TELO?
Rallies AI research for TELO combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is TELO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TELO. It does not provide personalized investment advice.
TELO

TELO